Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 13 years
- Director since
- 2023
13 years of board service in total across 4 boards, counting each seat separately. Longest: Scilex Holding Company, 3 years.
Scilex Holding Company
Director
United Therapeutics Corporation
Director
TherapeuticsMD Inc.
Director
Healthpeak Properties Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | United Therapeutics Corporation | Option exercise | +2,000 | $101.80 | $203,600 |
| Mar 26, 2026 | United Therapeutics Corporation | Open-market sale | −275 | $537.62 | $147,846 |
| Mar 26, 2026 | United Therapeutics Corporation | Open-market sale | −1,414 | $539.25 | $762,500 |
| Mar 26, 2026 | United Therapeutics Corporation | Open-market sale | −311 | $540.18 | $167,996 |
| Mar 4, 2026 | United Therapeutics Corporation | Option exercise | +2,000 | $101.80 | $203,600 |
| Mar 4, 2026 | United Therapeutics Corporation | Open-market sale | −2,000 | $489.42 | $978,840 |
| Dec 23, 2025 | TherapeuticsMD Inc. | Open-market purchase | +8,400 | $1.67 | $14,028 |
| Dec 18, 2025 | United Therapeutics Corporation | Option exercise | +910 | $101.80 | $92,638 |
| Dec 18, 2025 | United Therapeutics Corporation | Open-market sale | −910 | $500.59 | $455,537 |
| Sep 10, 2025 | United Therapeutics Corporation | Option exercise | +4,560 | $229.81 | $1,047,934 |
| Sep 10, 2025 | United Therapeutics Corporation | Open-market sale | −4,560 | $403.36 | $1,839,322 |
| May 28, 2025 | Healthpeak Properties Inc. | Open-market purchase | +5,777 | $17.27 | $99,769 |
| May 9, 2025 | United Therapeutics Corporation | Option exercise | +2,500 | $175.43 | $438,575 |
| May 9, 2025 | Healthpeak Properties Inc. | Open-market purchase | +5,700 | $17.36 | $98,952 |
| May 9, 2025 | United Therapeutics Corporation | Open-market sale | −2,500 | $305.15 | $762,875 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.